Baca, Sylvan C.
Takeda, David Y.
Seo, Ji-Heui
Hwang, Justin
Ku, Sheng Yu http://orcid.org/0000-0003-4715-1888
Arafeh, Rand
Arnoff, Taylor
Agarwal, Supreet http://orcid.org/0000-0001-7924-6852
Bell, Connor
O’Connor, Edward
Qiu, Xintao http://orcid.org/0000-0002-8560-7017
Alaiwi, Sarah Abou http://orcid.org/0000-0002-7073-3432
Corona, Rosario I.
Fonseca, Marcos A. S.
Giambartolomei, Claudia http://orcid.org/0000-0003-2786-1225
Cejas, Paloma
Lim, Klothilda
He, Monica
Sheahan, Anjali
Nassar, Amin http://orcid.org/0000-0002-8084-9105
Berchuck, Jacob E. http://orcid.org/0000-0002-7607-2428
Brown, Lisha
Nguyen, Holly M.
Coleman, Ilsa M.
Kaipainen, Arja
De Sarkar, Navonil
Nelson, Peter S. http://orcid.org/0000-0002-5451-5726
Morrissey, Colm
Korthauer, Keegan
Pomerantz, Mark M.
Ellis, Leigh http://orcid.org/0000-0003-4739-5049
Pasaniuc, Bogdan
Lawrenson, Kate http://orcid.org/0000-0002-6469-2515
Kelly, Kathleen
Zoubeidi, Amina http://orcid.org/0000-0002-0498-142X
Hahn, William C. http://orcid.org/0000-0003-2840-9791
Beltran, Himisha http://orcid.org/0000-0003-3259-2226
Long, Henry W. http://orcid.org/0000-0001-6849-6629
Brown, Myles
Corey, Eva http://orcid.org/0000-0002-9244-3807
Freedman, Matthew L. http://orcid.org/0000-0002-0151-1238
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P50 CA097186, P01 CA163227)
U.S. Department of Defense (DOD W81XWH-19-1-0565, DOD W81XWH-17-1-0415)
U.S. Department of Health & Human Services | National Institutes of Health
Prostate Cancer Foundation
Pharmaceutical Research and Manufacturers of America Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009172)
Article History
Received: 30 September 2020
Accepted: 18 February 2021
First Online: 30 March 2021
Competing interests
: W.C.H. is a consultant for Thermo Fisher, Solasta Ventures, iTeos, Frontier Medicines, Tyra Biosciences, MPM Capital, KSQ Therapeutics, and Paraxel and is a founder of KSQ Therapeutics. All other authors declare no competing interests.